Home Mannkind to triple Afrezza production
 

Keywords :   


Mannkind to triple Afrezza production

2015-04-27 23:45:31| Biotech - Topix.net

Executives with Mannkind are tripling their production capacity at their local manufacturing facility in the hopes that demand for their drug Afrezza will continue to increase in the coming months. Afrezza, the first inhalable and fast acting insulin, hit the market in February after several years in development by the drug company.

Tags: production triple afrezza mannkind

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
18.06Apple scraps its Pay Later loan scheme in US
18.06Potential Tropical Cyclone One Public Advisory Number 2
18.06Summary for Potential Tropical Cyclone One (AT1/AL012024)
18.06Potential Tropical Cyclone One Graphics
18.06Potential Tropical Cyclone One Wind Speed Probabilities Number 2
18.06Potential Tropical Cyclone One Forecast Advisory Number 2
18.06Potential Tropical Cyclone One Graphics
18.06Atlantic Tropical Weather Outlook
More »